IgG4,k
Reset all filters

Min CHF:
Max CHF:
  1-30 of 229
Supplier Product name Cat.no. Pack size Price
Pembrolizumab Biosimilar - Research Grade ICH4029-100MG ICH4029-1MG ICH4029-5MG ICH4029-10MG ICH4029-20MG ICH4029-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
Anti-EGFR [C225 (Cetuximab)], Human IgG4 kappa, Purified Ab00279-13.0 Ab00279-13.0-BT 550,00 2'170,00
Anti-CD33 [hP67.6 (Gemtuzumab)], Human IgG4 kappa, Purified Ab00283-13.0 Ab00283-13.0-BT 550,00 2'170,00
Galcanezumab Biosimilar - Research Grade ICH5046-100MG ICH5046-1MG ICH5046-5MG ICH5046-10MG ICH5046-20MG ICH5046-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
Lebrikizumab Biosimilar - Research Grade ICH5058-100MG ICH5058-1MG ICH5058-5MG ICH5058-10MG ICH5058-20MG ICH5058-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
Tralokinumab Biosimilar - Research Grade ICH5059-100MG ICH5059-1MG ICH5059-5MG ICH5059-10MG ICH5059-20MG ICH5059-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
Gemtuzumab Biosimilar - Research Grade ICH5073-100MG ICH5073-1MG ICH5073-5MG ICH5073-10MG ICH5073-20MG ICH5073-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
Fresolimumab Biosimilar - Research Grade ICH5077-100MG ICH5077-1MG ICH5077-5MG ICH5077-10MG ICH5077-20MG ICH5077-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
Sabatolimab Biosimilar - Research Grade ICH5079-100MG ICH5079-1MG ICH5079-5MG ICH5079-10MG ICH5079-20MG ICH5079-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
  1-30 of 229

Customer Support
T +41 41 420 96 36
F +41 41 420 96 56
info@lucerna-chem.ch

Business Hours
Monday to Friday
08:00 – 12:00
13:00 – 17:00

Technical Support
tech@lucerna-chem.ch
Business Development
business.dev@lucerna-chem.ch

Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern

© Copyright 2021 Lucerna-Chem AG, Switzerland

Order Conditions | Privacy Policy | Terms & Conditions | Impressum